These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14764586)

  • 1. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate.
    Gervois P; Kleemann R; Pilon A; Percevault F; Koenig W; Staels B; Kooistra T
    J Biol Chem; 2004 Apr; 279(16):16154-60. PubMed ID: 14764586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
    Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator- activated receptor alpha agonists.
    Yamazaki K; Kuromitsu J; Tanaka I
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1114-22. PubMed ID: 11798191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta.
    Gervois P; Vu-Dac N; Kleemann R; Kockx M; Dubois G; Laine B; Kosykh V; Fruchart JC; Kooistra T; Staels B
    J Biol Chem; 2001 Sep; 276(36):33471-7. PubMed ID: 11418615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1.
    Delerive P; De Bosscher K; Besnard S; Vanden Berghe W; Peters JM; Gonzalez FJ; Fruchart JC; Tedgui A; Haegeman G; Staels B
    J Biol Chem; 1999 Nov; 274(45):32048-54. PubMed ID: 10542237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 inhibition of peroxisome proliferator-activated receptor alpha expression is mediated by JAK2- and PI3K-induced STAT1/3 in HepG2 hepatocyte cells.
    Chew GS; Myers S; Shu-Chien AC; Muhammad TS
    Mol Cell Biochem; 2014 Mar; 388(1-2):25-37. PubMed ID: 24242046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonists down-regulate alpha2-macroglobulin expression by a PPARalpha-dependent mechanism.
    González MC; Corton JC; Cattley RC; Herrera E; Bocos C
    Biochimie; 2009 Aug; 91(8):1029-35. PubMed ID: 19497347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
    Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
    Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.
    Brisson D; Ledoux K; Bossé Y; St-Pierre J; Julien P; Perron P; Hudson TJ; Vohl MC; Gaudet D
    Pharmacogenetics; 2002 Jun; 12(4):313-20. PubMed ID: 12042669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway.
    Edgar AD; Tomkiewicz C; Costet P; Legendre C; Aggerbeck M; Bouguet J; Staels B; Guyomard C; Pineau T; Barouki R
    Toxicol Lett; 1998 Sep; 98(1-2):13-23. PubMed ID: 9776557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate, a peroxisome proliferator-activated receptor alpha activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats.
    Maruyama S; Kato K; Kodama M; Hirono S; Fuse K; Nakagawa O; Nakazawa M; Miida T; Yamamoto T; Watanabe K; Aizawa Y
    J Atheroscler Thromb; 2002; 9(2):87-92. PubMed ID: 12236317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
    Kockx M; Princen HM; Kooistra T
    Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia.
    Hill MR; Clarke S; Rodgers K; Thornhill B; Peters JM; Gonzalez FJ; Gimble JM
    Infect Immun; 1999 Jul; 67(7):3488-93. PubMed ID: 10377130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor alpha negatively regulates T-bet transcription through suppression of p38 mitogen-activated protein kinase activation.
    Jones DC; Ding X; Zhang TY; Daynes RA
    J Immunol; 2003 Jul; 171(1):196-203. PubMed ID: 12816998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of retinol binding protein 4 by Interleukin-6 via peroxisome proliferator-activated receptor α and CCAAT/Enhancer binding proteins.
    Mohd MA; Ahmad Norudin NA; Muhammad TST
    Mol Cell Endocrinol; 2020 Apr; 505():110702. PubMed ID: 31927097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice.
    Inoue H; Jiang XF; Katayama T; Osada S; Umesono K; Namura S
    Neurosci Lett; 2003 Dec; 352(3):203-6. PubMed ID: 14625020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro.
    Kleemann R; Verschuren L; de Rooij BJ; Lindeman J; de Maat MM; Szalai AJ; Princen HM; Kooistra T
    Blood; 2004 Jun; 103(11):4188-94. PubMed ID: 14976045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
    Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
    Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate increases homocystinemia through a PPARalpha-mediated mechanism.
    Luc G; Jacob N; Bouly M; Fruchart JC; Staels B; Giral P
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):452-3. PubMed ID: 15076230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.